666

ZHEJIANG ORIENT GENE BIOTECH CO., LTD

No trades
See on Supercharts
Market capitalization
‪5.51 B‬CNY
−1.80CNY
‪−372.07 M‬CNY
‪824.13 M‬CNY
‪103.70 M‬
Beta (1Y)
1.15

About ZHEJIANG ORIENT GENE BIOTECH CO., LTD

CEO
Jian Qiu Fang
Headquarters
Huzhou
Founded
2005
ISIN
CNE100003RM8
FIGI
BBG00P48KPH6
Zhejiang Orient Gene Biotech Co., Ltd. engages in the research, development, production and sales of in vitro diagnostic products. Its main product includes point-of-care testing instant diagnostic reagent. The company also focuses on the development of molecular diagnostics, biological materials, diagnostic instruments and liquid biochips business. The company was founded on December 1, 2005 and is headquartered in Huzhou, China.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬
Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

The current price of 688298 is 27.25 CNY — it has decreased by 0.26% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on SSE exchange ZHEJIANG ORIENT GENE BIOTECH CO., LTD stocks are traded under the ticker 688298.
688298 stock is 1.93% volatile and has beta coefficient of 1.15. Check out the list of the most volatile stocks — is ZHEJIANG ORIENT GENE BIOTECH CO., LTD there?
Yes, you can track ZHEJIANG ORIENT GENE BIOTECH CO., LTD financials in yearly and quarterly reports right on TradingView.
688298 stock has fallen by 0.84% compared to the previous week, the month change is a 13.49% fall, over the last year ZHEJIANG ORIENT GENE BIOTECH CO., LTD has showed a 43.62% decrease.
688298 net income for the last quarter is ‪−304.80 M‬ CNY, while the quarter before that showed ‪−107.19 M‬ CNY of net income which accounts for −184.35% change. Track more ZHEJIANG ORIENT GENE BIOTECH CO., LTD financial stats to get the full picture.
Today ZHEJIANG ORIENT GENE BIOTECH CO., LTD has the market capitalization of ‪5.51 B‬, it has decreased by 1.43% over the last week.
Yes, 688298 dividends are paid annually. The last dividend per share was 2.00 CNY. As of today, Dividend Yield (TTM)% is 5.08%. Tracking ZHEJIANG ORIENT GENE BIOTECH CO., LTD dividends might help you take more informed decisions.
Like other stocks, 688298 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade ZHEJIANG ORIENT GENE BIOTECH CO., LTD stock right from TradingView charts — choose your broker and connect to your account.
688298 reached its all-time high on Jan 14, 2022 with the price of 245.01 CNY, and its all-time low was 25.00 CNY and was reached on Feb 5, 2024.
See other stocks reaching their highest and lowest prices.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So ZHEJIANG ORIENT GENE BIOTECH CO., LTD technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating ZHEJIANG ORIENT GENE BIOTECH CO., LTD stock shows the sell signal. See more of ZHEJIANG ORIENT GENE BIOTECH CO., LTD technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.